Featured Products & Services
-
GenVoy-ILM™ T-Cell Kits For mRNA
4/24/2025
Off-the-shelf, research use only lipid nanoparticle (LNP) reagents to deliver RNA into T-cells.
-
ÄKTA oligosynt™ Oligonucleotide Synthesizer
3/28/2022
The ÄKTA oligosynt™ oligonucleotide synthesizer is a compact, fully automated oligonucleotide synthesizer built for research and process development laboratories. The system supports a robust and easily scalable oligonucleotide synthesis process and transfer to larger oligonucleotide synthesizers with high yield and quality.
-
Automated Single-Use Filtration System For Small-Scale Manufacturing
11/15/2017
This automated single-use filtration system for pilot- and small-scale manufacturing features a single-use flow path that addresses the bioburden challenge, reducing the need for cleaning to shorten batch changeover time.
-
Orphan And Rare Disease CRO Services
11/7/2023
Rare disease clinical studies demand a specialized full-service CRO with expertise in enrollment, site selection, and global regulatory knowledge for accelerated recruitment.
-
Chain Of Compliance: Enabling A Significantly Smarter Supply Chain
12/1/2022
Companies vying to be the first to market with breakthrough treatments have a great deal riding on the success of their efforts. Incorporating innovative processes, ethical considerations, assuring the safety and efficacy of the product, and managing the commodity's environmental control are formidable challenges that often lack standardized quality control procedures. Precision medicine requires end-to-end traceability: everything from chain of custody, to chain of condition, to chain of identity. The fragility of regenerative medicine therapies and the need to manage risk means a fourth link in the chain will soon be a regulatory requirement.
-
Virosart® Media Lab Modules
6/13/2016
Virus-retentive filtration is a highly efficient method for viral risk mitigation of cell culture media. This filter targets both non-enveloped viruses, such as MVM and vesivirus, and large enveloped viruses, such as MLV. Virosart® Media is especially designed for virus filtration of chemically defined cell culture media.
-
NanoAssemblr™ Ignite And Ignite+ Nanoparticle Formulation Systems
10/21/2026
The NanoAssemblr™ Ignite and Ignite+ systems provide an easy-to-use, scalable platform for reproducible lipid nanoparticle formulation. Choose the workflow and cartridge-use approach that fits your program today, with a validated path to clinical and commercial manufacturing when you are ready.
-
Excellence For Cell And Gene Therapy Manufacturing
6/4/2025
Unlock the potential of advanced therapies with dedicated partnership and tailored manufacturing solutions, ensuring quality and efficiency from discovery through to delivery for next-generation treatments.
-
Bionanoparticle Technology
4/24/2023
Nanoform’s proprietary bionanoparticle technology can deliver large-molecule drug particles as small as 50 nm while retaining biological activity. This can not only enable more patient-friendly approaches to drug delivery, but also potentially higher loads of active ingredients.
-
Small Scale Proof. Large Scale Confidence.
1/16/2026
Proof of concept studies with a proven path to manufacturing success.